510(k) Report

510(k) · Cleared

Cleared

Augmented VaultLock Glenoid

K210050510(k) TraditionalCleared Jun 7, 2021150-day reviewClass II21 CFR 888.3660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Arthrex, Inc. · KWS Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer Cemented

Cleared on Jun 7, 2021 as substantially equivalent to K161108 (Arthrex, Inc., 2016) after a 150-day review. Its family tree reaches back 5 generations to 2001.

Decided
Jun 7, 2021
Review
150 days
Class
Class II
Product code
KWS
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K010124 (2001). No later device cites it as a predicate yet.

  1. Root · 5 generations backK010124 Arthrex Univers 30 Shoulder ProsthesisArthrex, Inc. · 2001
  2. 4 generations backK071032 Arthrex Univers II Shoulder ProsthesisArthrex, Inc. · 2007
  3. 3 generations backK083435 Arthrex Univers II Shoulder Pegged GlenoidArthrex, Inc. · 2009
  4. 2 generations backK120044 Arthrex Universii XL Glenoid-Pegged, Arthrex Univers II XL…Arthrex, Inc. · 2012
  5. 1 generation backK161108 Arthrex VaultLock GlenoidArthrex, Inc. · 2016
  6. This deviceK210050 Augmented VaultLock GlenoidArthrex, Inc. · 2021
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K010124Arthrex Univers 30 Shoulder ProsthesisArthrex, Inc.2001—
−4K071032Arthrex Univers II Shoulder ProsthesisArthrex, Inc.2007—
−3K083435Arthrex Univers II Shoulder Pegged GlenoidArthrex, Inc.2009—
−2K120044Arthrex Universii XL Glenoid-Pegged, Arthrex Univers II XL Glenoid-KeeledArthrex, Inc.2012—
−1K161108Arthrex VaultLock GlenoidArthrex, Inc.2016—
0 (this device)K210050Augmented VaultLock GlenoidArthrex, Inc.2021—
FIG. 1 — Lineage of K210050, 2001–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KWS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KWS device

  1. #1 K220847 AETOS Shoulder Systemscore 21.1 · 16 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K161108Arthrex VaultLock Glenoid
Summary page 4
…KWS Classification Name 21 CFR 888.3660: Prosthesis, Shoulder, semi-constrained metal/polymer, cemented Regulatory Class II Predicate Device K161108: Arthrex VaultLock Glenoid Reference Device K191960: Arthrex Univers Revers Modular Glenoid System…
Arthrex, Inc.2016—
†K191960Arthrex Univers Revers Modular Glenoid SystemArthrex, Inc.2019—
†K071032Arthrex Univers II Shoulder ProsthesisArthrex, Inc.2007—

Also cleared against K161108: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 1 company; a new generation was cleared every 4.5 years on median.
  • None of the 5 ancestors has a recall.
  • 1 other device also cites its predicate K161108.

How does its category compare?

All KWS devices

KWS Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer Cemented: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · KWS

3in 2025

2007: 22008: 42009: 42010: 72011: 112012: 72013: 122014: 72015: 82016: 102017: 72018: 42019: 92020: 32021: 52022: 52023: 42024: 22025: 32026 (partial year): 2
2007high 12 (2013) · low 2 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KWS

97in 2025

2008: 37 days median2009: 108 days median2010: 33 days median2011: 90 days median2012: 86 days median2013: 120 days median2014: 89 days median2015: 129 days median2016: 114 days median2017: 120 days median2018: 152 days median2019: 106 days median2020: 98 days median2021: 151 days median2022: 158 days median2023: 250 days median2025: 97 days median
2007high 250 (2023) · low 33 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KWS

2in 2023

2007: 212008: 292010: 102011: 112012: 102014: 12016: 12017: 42018: 12019: 22020: 52023: 22026 (partial year): 1
2007high 29 (2008) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KWS

2,281in 2025

2007: 1582008: 2382009: 2942010: 3932011: 4862012: 5422013: 8182014: 1,0662015: 1,1702016: 9702017: 1,6812018: 1,5452019: 1,7282020: 1,5672021: 1,3582022: 1,2682023: 1,7502024: 2,1222025: 2,281
2007high 2,281 (2025) · low 158 (2007)2025

MAUDE reports naming product code KWS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—21158
200843729238
200941080294
201073310393
2011119011486
201278610542
2013121200818
201478911,066
2015812901,170
2016101141970
2017712041,681
2018415211,545
2019910621,728
202039851,567
2021515101,358
2022515801,268
2023425021,750
20242—02,122
202539702,281
20262—1—

What is it indicated for?

The Augmented VaultLock Glenoid is indicated in replacement(s) when conditions include severe pain or significant disability resulting from degenerative, rheumatoid, traumatic disease, or injury of the glenohumeral joint; non-union humeral head fractures of long duration; irreducible 2- and 4- part proximal humeral fractures; avascular necrosis of the humeral head; or, other difficult clinical management problems where arthrodesis or resectional arthroplasty is not acceptable.

The glenoid components are designed for cemented fixation in the joint and must only be used with appropriate bone cement.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K210050: Augmented VaultLock Glenoid.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K210050

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026